July 2023 3
Enrolling By Invitation
99 years or below
Male
Phase
1
Brief description of study
This post-market, prospective, interventional, global, multi-center, randomized, nonblinded, dual-arm, clinical trial study will generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft System versus Gore Excluder/Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysm (AAA). The primary objective is to evaluate sac regression outcomes in standard EVAR subjects.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: Male
TBD
Updated on
04 Aug 2024.
Study ID: 786554
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
